 Mesna
"Mesna" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE.
| Descriptor ID |
D015080
|
| MeSH Number(s) |
D02.455.326.146.100.050.490 D02.886.489.590 D02.886.645.600.055.050.500
|
| Concept/Terms |
Mesna- Mesna
- Sodium 2-Mercaptoethanesulphonate
- 2-Mercaptoethanesulphonate, Sodium
MESNA-cell- MESNA-cell
- MESNA cell
- cell pharm Brand of Mesna
Ziken- Ziken
- Kendrick Brand of Mesna
- Mesna Kendrick Brand
Mistabron- Mistabron
- Mucofluid
- UCB Brand of Mesna
- Mistabronco
Uromitexan- Uromitexan
- Sanfer Brand of Mesna
- Mesna Sanfer Brand
- ASTA Medica Brand of Mesna
Mesnex- Mesnex
- Bristol-Myers Squibb Brand of Mesna
- Bristol Myers Squibb Brand of Mesna
|
Below are MeSH descriptors whose meaning is more general than "Mesna".
Below are MeSH descriptors whose meaning is more specific than "Mesna".
This graph shows the total number of publications written about "Mesna" by people in this website by year, and whether "Mesna" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2008 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 | | 2015 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mesna" by people in Profiles.
-
Uy GL, Hsu YM, Schmidt AP, Stock W, Fletcher TR, Trinkaus KM, Westervelt P, DiPersio JF, Link DC. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia. Leuk Res. 2015 Dec; 39(12):1437-42.
-
Miller RC, Murley JS, Grdina DJ. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiat Res. 2014 May; 181(5):464-70.
-
Esser-Kahn AP, Francis MB. Protein-cross-linked polymeric materials through site-selective bioconjugation. Angew Chem Int Ed Engl. 2008; 47(20):3751-4.
-
Murley JS, Kataoka Y, Cao D, Li JJ, Oberley LW, Grdina DJ. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res. 2004 Nov; 162(5):536-46.
-
Thomson B, Park JR, Felgenhauer J, Meshinchi S, Holcenberg J, Geyer JR, Avramis V, Douglas JG, Loken MR, Hawkins DS. Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse. Pediatr Blood Cancer. 2004 Oct; 43(5):571-9.
-
Grdina DJ, Murley JS, Kataoka Y. Radioprotectants: current status and new directions. Oncology. 2002; 63 Suppl 2:2-10.
-
Czyzewski EA, Goldman S, Mundt AJ, Nachman J, Rubin C, Hallahan DE. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study. Int J Radiat Oncol Biol Phys. 1999 Jun 01; 44(3):569-77.
-
Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies. Semin Oncol. 1996 Jun; 23(3 Suppl 6):11-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|